CyDex Pharma Begins Patient Dosing For Phase 2A Oncology Drug Trial
Melphalan is an FDA-approved chemotherapy for the palliative treatment of multiple myeloma marketed under the brand name Alkeran by GlaxoSmithKline. CyDex said that the trial will compare the
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.